Putnam Investments’s Array Biopharma Inc ARRY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q3 | – | Sell |
-110,987
| Closed | -$5.14M | – | 967 |
|
|
2019
Q2 | $5.14M | Sell |
110,987
-83,796
| -43% | -$2.35M | 0.01% | 507 |
|
|
2019
Q1 | $4.75M | Hold |
194,783
| – | – | 0.01% | 522 |
|
|
2018
Q4 | $2.78M | Hold |
194,783
| – | – | 0.01% | 580 |
|
|
2018
Q3 | $2.96M | Buy |
194,783
+53,584
| +38% | +$821K | 0.01% | 693 |
|
|
2018
Q2 | $2.37M | Buy |
141,199
+1,195
| +0.9% | +$19K | 0.01% | 688 |
|
|
2018
Q1 | $2.29M | Sell |
140,004
-160,024
| -53% | -$2.56M | 0.01% | 687 |
|
|
2017
Q4 | $3.84M | Sell |
300,028
-40,140
| -12% | -$457K | 0.01% | 582 |
|
|
2017
Q3 | $4.18M | Sell |
340,168
-463,841
| -58% | -$4.31M | 0.01% | 556 |
|
|
2017
Q2 | $6.73M | Buy |
804,009
+218,307
| +37% | +$1.79M | 0.02% | 451 |
|
|
2017
Q1 | $5.24M | Buy |
585,702
+359,939
| +159% | +$3.83M | 0.01% | 566 |
|
|
2016
Q4 | $1.98M | Buy |
225,763
+90,922
| +67% | +$669K | ﹤0.01% | 841 |
|
|
2016
Q3 | $910K | Buy |
+134,841
| New | +$522K | ﹤0.01% | 1036 |
|
|
2015
Q1 | – | Sell |
-193,585
| Closed | -$916K | – | 1567 |
|
|
2014
Q4 | $916K | Sell |
193,585
-1,122
| -0.6% | -$4.44K | ﹤0.01% | 1193 |
|
|
2014
Q3 | $695K | Buy |
194,707
+3,726
| +2% | +$14.7K | ﹤0.01% | 1279 |
|
|
2014
Q2 | $871K | Buy |
190,981
+262
| +0.1% | +$1.08K | ﹤0.01% | 1214 |
|
|
2014
Q1 | $897K | Sell |
190,719
-9,795
| -5% | -$49.3K | ﹤0.01% | 1224 |
|
|
2013
Q4 | $1M | Sell |
200,514
-685,849
| -77% | -$3.73M | ﹤0.01% | 1201 |
|
|
2013
Q3 | $5.51M | Sell |
886,363
-15,483
| -2% | -$92K | 0.01% | 667 |
|
|
2013
Q2 | $4.09M | Buy |
+901,846
| New | +$4.85M | 0.01% | 785 |
|
Other funds holding ARRY
Putnam Investments's ARRY Position: Q3 2019 in Review
Putnam Investments sold out of Array Biopharma Inc (ARRY) in Q3 2019, closing a stake of 110,987 shares — an estimated $5.14M sold.
Putnam Investments first reported a position in ARRY in Q2 2013 and held it in 19 quarters. The position peaked at $6.73M in Q2 2017. 1 fund tracked by Wall St. Rank holds ARRY as of Q3 2019.
- Putnam Investments reported no remaining Array Biopharma Inc position as of Q3 2019 after selling out during the quarter.
- Putnam Investments sold 110,987 Array Biopharma Inc shares in Q3 2019, an estimated $5.14M.
- Putnam Investments first reported a position in Array Biopharma Inc in Q2 2013 and held it in 19 quarters.
- Putnam Investments's Array Biopharma Inc position peaked at $6.73M in Q2 2017.
- 1 fund tracked by Wall St. Rank held Array Biopharma Inc as of Q3 2019.
Based on Putnam Investments's 13F filing for Q3 2019, filed 14 Nov 2019.